Hormonal birth control may reduce ovarian cancer risk in people with BRCA mutations
Full article:

Hormonal birth control pill is linked to reduced ovarian cancer among people with an inherited BRCA mutation. Longer-acting forms of birth control given by implant, injection or as an intrauterine device may be associated with lower ovarian cancer risk for people with an inherited BRCA mutation. (Posted 4/28/23)

Este artículo está disponible en español.

Questions To Ask Your Health Care Provider

If you have a BRCA1/2 mutation and you need birth control:

Open Clinical Trials

The National Comprehensive Cancer Network (NCCN) provides guidelines for management of gynecologic cancer risk in people with BRCA1 and BRCA2 mutations. 



The following are studies looking at ovarian cancer screening or prevention.  ​​​​​

Additional clinical trials for ovarian cancer screening and prevention may be found here.

The following resources focus on BRCA1 and BRCA2 mutations. 



FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.